Asia Pacific Herald
SEE OTHER BRANDS

The latest news from Asia and the Pacific

Asia Pacific Herald: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific Herald.

Press releases published on June 2, 2025

Potential Therapy Equipment Market Valued at $18Billion  in 2024, Rising to $32Billion  by 2034 | Exactitude Consultancy

Potential Therapy Equipment Market Valued at $18Billion in 2024, Rising to $32Billion by 2034 | Exactitude Consultancy

Luton, Bedfordshire, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- Potential Therapy Equipment Market Research Report As of 2024, the global market for potential therapy equipment is valued at approximately $18 billion. The market is poised for …

Crystal and Oscillators Market Valued at $7.5 Billion in 2024, Expected to Reach $11.2 Billion by 2034 | Exactitude Consultancy

Crystal and Oscillators Market Valued at $7.5 Billion in 2024, Expected to Reach $11.2 Billion by 2034 | Exactitude Consultancy

Luton, Bedfordshire, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- The global crystal and oscillators market is poised for steady growth, expected to rise from approximately USD 7.5 billion in 2024 to around USD 11.2 billion by 2034. This reflects a …

Interventional Pulmonology Device Market Valued at $6.2B in 2024, Forecast to Exceed $10B by 2034 | Exactitude Consultancy

Interventional Pulmonology Device Market Valued at $6.2B in 2024, Forecast to Exceed $10B by 2034 | Exactitude Consultancy

Luton, Bedfordshire, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- Market Overview The global interventional pulmonology device market is projected to reach USD 6.2 billion in 2024 and is expected to exceed USD 10 billion by 2034, growing at a CAGR of …

Senior-Friendly Packaging Market to Reach USD 8,747.657 Million by 2035, Driven by Aging Population | FMI

Senior-Friendly Packaging Market to Reach USD 8,747.657 Million by 2035, Driven by Aging Population | FMI

Japan’s aging population drives demand for senior-friendly packaging, with easy-open, ergonomic designs now common in food, pharma, and personal care. NEWARK, DE, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- The senior friendly packaging market is …

Alfalfa Hay Market Size to worth Over US$ 23.38 Billion By 2031 | The Insight Partners

Alfalfa Hay Market Size to worth Over US$ 23.38 Billion By 2031 | The Insight Partners

US …

OceanPal Inc. Announces the Sale  of M/V Protefs

OceanPal Inc. Announces the Sale of M/V Protefs

ATHENS, Greece, June 02, 2025 (GLOBE NEWSWIRE) -- OceanPal Inc. (NASDAQ: OP) (the “Company”), a global shipping company specializing in the ownership of vessels, today announced that, through a separate wholly-owned subsidiary, it has signed a Memorandum …

High Grade Ni/PGE Adjoining Globex’s Tyrone Property

High Grade Ni/PGE Adjoining Globex’s Tyrone Property

ROUYN-NORANDA, Quebec, June 02, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …

G2A.COM introduces G2A Plus Free, a new package for its loyalty program  

G2A.COM introduces G2A Plus Free, a new package for its loyalty program  

AMSTERDAM, June 02, 2025 (GLOBE NEWSWIRE) -- Launched in 2017, G2A Plus is a loyalty program designed to enhance the shopping experience for buyers while supporting sellers in driving repeat purchases. Over the years it has provided real value across …

Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001, a First-in-Class BCMA × CD38 × CD3 Trispecific Antibody, for the Treatment of Relapsed/Refractory Multiple Myeloma

Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001, a First-in-Class BCMA × CD38 × CD3 Trispecific Antibody, for the Treatment of Relapsed/Refractory Multiple Myeloma

TRIgnite-1 study shows an overall response rate (ORR) of 74% across nine dose levels, in heavily pretreated patients with a median of six prior lines of therapy ORR is remarkably high in patients with no prior CAR-T or bispecific therapies (84%) as well as …

Rakovina Therapeutics Announces 2025 Q1 Financial Results and Provides Corporate Update

Rakovina Therapeutics Announces 2025 Q1 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing novel DNA-damage response (DDR) cancer therapies powered by artificial …

U.S. Unmanned Surface Vehicles Market to Hit $362.4 Million by 2028 – Size, Share and Analysis

U.S. Unmanned Surface Vehicles Market to Hit $362.4 Million by 2028 – Size, Share and Analysis

Delray Beach, FL, June 02, 2025 (GLOBE NEWSWIRE) -- The report "US Unmanned Surface Vehicles Market by Type [Autonomous, Semi-Autonomous], Application (Defense, Commercial), Solution, Cruising Speed, Hull Type, Endurance, Size and Region - Forecasts to …

NewGen Announces Planned $30 Million Strategic Investment in Solana Digital Asset Staking

NewGen Announces Planned $30 Million Strategic Investment in Solana Digital Asset Staking

BANGKOK, June 02, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced plans …

Robex Reports Operational and Financial Results for Q1 2025

Robex Reports Operational and Financial Results for Q1 2025

QUÉBEC CITY, June 02, 2025 (GLOBE NEWSWIRE) -- Robex Resources Inc. ("Robex" or the "Company") (TSXV: RBX/ASX: RXR) Matthew Wilcox, Managing Director, commented: "The company has had a strong start to 2025, construction continues to advance at Kiniero, and …

Robotics Lubricants Market Size Expected to Surpass $14.25 Billion by 2031, Expanding at 11.0% CAGR from 2023-2031 | The Insight Partners

Robotics Lubricants Market Size Expected to Surpass $14.25 Billion by 2031, Expanding at 11.0% CAGR from 2023-2031 | The Insight Partners

US …

Fancamp Announces Appointment of CIO

Fancamp Announces Appointment of CIO

VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Fancamp Exploration Ltd. (“Fancamp” or the “Corporation”) (TSX Venture Exchange: FNC) is pleased to announce the appointment of Mr. Kit Spring to the position of Chief Investment Officer (“CIO …

Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting

Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting

31% confirmed ORR (8 responses in 26 evaluable patients) across B7-H4 high tumors at intermediate doses 44% confirmed ORR (7 responses in 16 evaluable patients) in the subset of patients with ≤4 prior lines of therapy CAMBRIDGE, Mass., June 02, 2025 (GLOBE …

Fasoo Smart Screen Bolsters Supply Chain Security with Advanced Screen Protection

Fasoo Smart Screen Bolsters Supply Chain Security with Advanced Screen Protection

SEOUL, SOUTH KOREA, June 2, 2025 /⁨EINPresswire.com⁩/ -- Fasoo, the leader in data-centric security, introduces new momentum for Fasoo Smart Screen (FSS), its advanced screen security solution designed to control unauthorized screen capture tools and …

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

Supports plans to advance the RV01 program to first-in-human therapeutic basket study in solid tumour cancers Data completes preclinical package for Investigational New Drug submission in mid-2025 with Phase 1 therapeutic study initiation expected in 4Q25 …

Enterome to present positive Phase 2 indolent non-Hodgkin lymphoma data for its OncoMimics™ EO2463 at ICML

Enterome to present positive Phase 2 indolent non-Hodgkin lymphoma data for its OncoMimics™ EO2463 at ICML

Presentation at the International Conference on Malignant Lymphoma (ICML) in Lugano on June 21 SIDNEY is an ongoing Phase 2 trial of EO2463 in 48   indolent Non-Hodgkin Lymphoma (iNHL) patients Enterome has held a positive Type-C meeting with FDA for …

SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting

SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting

- ASCO Presentation Supports SLS009 as a Potential Targeted Therapy for ASXL1 Mutated Colorectal Cancer – - 22,500 New Cases of Colorectal Cancer with High Microsatellite Instability per Year in the US: 55% ASXL1m Frequency – NEW YORK, June 02, 2025 (GLOBE …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service